1. Home
  2. KTTA vs AIXC Comparison

KTTA vs AIXC Comparison

Compare KTTA & AIXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.51

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo AIxCrypto Holdings Inc.

AIXC

AIxCrypto Holdings Inc.

HOLD

Current Price

$0.82

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
AIXC
Founded
2020
1996
Country
United States
United States
Employees
5
10
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
16.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KTTA
AIXC
Price
$0.51
$0.82
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
312.7K
28.2K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.62
52 Week High
$2.06
$2.98

Technical Indicators

Market Signals
Indicator
KTTA
AIXC
Relative Strength Index (RSI) 37.76 45.85
Support Level $0.42 $0.65
Resistance Level $0.52 $1.45
Average True Range (ATR) 0.04 0.10
MACD 0.00 0.02
Stochastic Oscillator 21.94 73.45

Price Performance

Historical Comparison
KTTA
AIXC

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About AIXC AIxCrypto Holdings Inc.

AIxCrypto Holdings Inc is a technology infrastructure company focused on the convergence of artificial intelligence and blockchain-based programmable systems. The Company develops software platforms and programmable infrastructure designed to facilitate the tokenization of real-world assets (RWA) and the deployment of Embodied Artificial Intelligence (EAI) in commercial environments. Its mission is to serve as the regulated, programmable infrastructure layer connecting traditional capital markets with on-chain systems and AI-enabled commercial systems.

Share on Social Networks: